JP2024525897A5 - - Google Patents
Info
- Publication number
- JP2024525897A5 JP2024525897A5 JP2024503567A JP2024503567A JP2024525897A5 JP 2024525897 A5 JP2024525897 A5 JP 2024525897A5 JP 2024503567 A JP2024503567 A JP 2024503567A JP 2024503567 A JP2024503567 A JP 2024503567A JP 2024525897 A5 JP2024525897 A5 JP 2024525897A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- inhibitor according
- nlrp3 inhibitor
- subject
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163224890P | 2021-07-23 | 2021-07-23 | |
| US63/224,890 | 2021-07-23 | ||
| PCT/IB2022/056695 WO2023002399A1 (en) | 2021-07-23 | 2022-07-20 | Dosing regimen for an nlrp3 inhibitor in the treatment of osteoarthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525897A JP2024525897A (ja) | 2024-07-12 |
| JP2024525897A5 true JP2024525897A5 (https=) | 2025-07-28 |
Family
ID=82846336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503567A Pending JP2024525897A (ja) | 2021-07-23 | 2022-07-20 | 変形性関節症の治療におけるｎｌｒｐ３阻害剤の投与計画 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250082611A1 (https=) |
| EP (1) | EP4373489A1 (https=) |
| JP (1) | JP2024525897A (https=) |
| KR (1) | KR20240038995A (https=) |
| CN (1) | CN117693340A (https=) |
| CA (1) | CA3224774A1 (https=) |
| IL (1) | IL309085A (https=) |
| WO (1) | WO2023002399A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS65962B1 (sr) | 2020-05-08 | 2024-10-31 | Halia Therapeutics Inc | Inhibitori nek7 kinaze |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS65492B1 (sr) | 2017-07-24 | 2024-05-31 | Novartis Ag | Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću nlrp |
| CN112654350A (zh) * | 2018-07-03 | 2021-04-13 | 诺华股份有限公司 | 使用nlrp3拮抗剂治疗对tnf抑制剂有抗性的受试者或针对所述患者选择治疗的方法 |
| GB201916237D0 (en) * | 2019-11-07 | 2019-12-25 | Inflazome Ltd | Novel treatment |
-
2022
- 2022-07-20 IL IL309085A patent/IL309085A/en unknown
- 2022-07-20 KR KR1020247005666A patent/KR20240038995A/ko active Pending
- 2022-07-20 CN CN202280049591.4A patent/CN117693340A/zh active Pending
- 2022-07-20 EP EP22751844.6A patent/EP4373489A1/en active Pending
- 2022-07-20 JP JP2024503567A patent/JP2024525897A/ja active Pending
- 2022-07-20 US US18/580,781 patent/US20250082611A1/en active Pending
- 2022-07-20 WO PCT/IB2022/056695 patent/WO2023002399A1/en not_active Ceased
- 2022-07-20 CA CA3224774A patent/CA3224774A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP3806427B2 (ja) | 新規鎮痛剤 | |
| WO2016062283A1 (zh) | 抗发炎用药物在制备抑制癌症的医药组合物中的应用 | |
| JP2011190199A (ja) | 関節リウマチ薬 | |
| JP2024516795A (ja) | エベロリムスおよびアムセネストラントを含む組合せ物 | |
| JP2007302657A (ja) | 痙症の兆候および症候の緩和方法 | |
| JP2009501801A5 (https=) | ||
| JP2024525897A5 (https=) | ||
| JP2018519340A5 (https=) | ||
| JP2023546140A5 (https=) | ||
| JP2009545546A (ja) | リウマチ性疾患の遅延放出型グルココルチコイド治療 | |
| JP2023549849A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| KR20230088753A (ko) | 파킨슨병 치료를 위한 오피카폰 및 레보도파 | |
| JP2019532112A (ja) | 結節性痒疹の治療方法 | |
| Patil et al. | A comparative analysis of the efficacy and safety of Nimesulide/Paracetamol fixed-dose combination with other NSAIDs in Acute Pain Management: a randomized, prospective, Multicenter, active-controlled study (the SAFE-2 study) | |
| WO2016101324A1 (zh) | 含有酶的天然组合物及其在制药中的应用 | |
| WO2018163119A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| EP4281071A1 (en) | Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa | |
| ES2554332T3 (es) | Utilización de la bencidamina en el tratamiento de las enfermedades dependientes de p40 | |
| JP2021530568A5 (https=) | ||
| EP3323416B1 (en) | Pharmaceutical composition for treating premature ejaculation | |
| CN116323604A (zh) | 5-甲基-1,2,4-噁二唑-3-基化合物的低剂量方案和制剂 | |
| CN102283834B (zh) | 一种含奥利司他的药物组合物及用途 | |
| JP2023528884A (ja) | 疾患の処置用の２－（ジエチルアミノ）エチル２－（４－イソブチルフェニル）プロピオネートの局所投与 |